Fresh perspective - Viewing pharma innovation differently reveals new opportunities

by CAS, a division of the American Chemical Society

4 years ago
analysis, drugs, pharmaceutical, innovation, opportunities

Innovation in the biopharmaceutical industry is a closely monitored driver of positive public health and commercial outcomes. Despite high interest in tracking innovation as a measure of success, ther...

ORYZON presents efficacy and safety results of its CLEPSIDRA trial with iadademstat in ED-SCLC patients at ESMO-2020

by Oryzon Genomics

4 years ago
lung cancer, CLEPSIDRA, iadademstat, ESMO, epigenetics, drugs

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announces today...

UB study identifies a new pharmacological target against Alzheimer’s disease

by Universitat de Barcelona

4 years ago
neuroinflammatory, drugs, alzhéimer

A UB study published in the journal Neurotherapeutics has validated a new pharmacological target for Alzheimer’s disease. The results show the inhibition of the enzyme soluble epoxide hydrolase (...

New tool for studying a key drug target

by UPF - Universitat Pompeu Fabra

4 years ago
Alzheimer’s, cancer, drugs

The results from this study, published in Nature Methods, can support the development of new drugs fighting Alzheimer’s disease or cancer.

Launch of Gate2Brain, the 'key' to transporting drugs into the brain and improving their effectiveness

by Fundació Bosch i Gimpera

4 years ago
pediatric glioma, Gate2Brain, IRB Barcelona, UB, SJD, drugs, brain

Researchers from IRB Barcelona, the University of Barcelona (UB) and the Sant Joan de Déu Research Institute – Hospital Sant Joan de Déu (SJD) have set up Gate2Brain, a company based on a novel te...

VarmX raises €32 million in Series B round led by Ysios Capital and INKEF Capital

by Ysios Capital

4 years ago
INKEF Capital, Lundbeckfonden Ventures, LSP, BioGeneration Ventures, InnovationQuarter, VarmX, Ysios Capital, drugs, anticoagulation, thrombosis

The oversubscribed round was co-led by Ysios Capital and INKEF Capital; Lundbeckfonden Ventures and LSP joined the syndicate. Founding investor, BioGeneration Ventures (BGV) and the regional economic ...

DeepUll closes Series A Financing led by Alta Life Sciences and Kurma Partners, to improve early diagnosis of sepsis

by Alta Life Sciences / CDTI

4 years ago
DeepUll, Kurma Partners, Sofimac Innovation, Mérieux Equity Partners, Fond-ICOpyme, Axis, sepsis, technology, drugs

DeepUll announced today the closing of a 3.5 million Euro round Series A financing led by Alta Life Sciences and Kurma Partners and with participation from Axis Participaciones Empresariales and Sofim...

Asphalion attended the online session 'Improving Human Health Through Artificial Intelligence'

by Asphalion

4 years ago
cybersecurity, medical devices, Artificial Intelligence, healthcare, drugs, software

Rainer Rothe, Scientific and Regulatory Affairs Officer at Asphalion, attended the online session “Improving Human Health Through Artificial Intelligence” organised by CataloniaBio & HealthTech in...

Ysios Capital presents its third fund of € 200M

by Ysios Capital

4 years ago
Ysios BioFund III, Ysios Capital, invest, drugs

Ysios Capital, a leading biotechnology venture capital firm in Spain, today announced its third fund, Ysios BioFund III, with a committed amount of € 155M and a final target size of € 200M.

Supercomputing to find drugs against SARS-CoV-2

by CSIC - Centro Superior de Investigaciones Científicas

4 years ago
supercomputing, drugs, covid-19, pandemics

The COVID-19 fund of the Carlos III Health Institute (ISCIII) awards a project to the Barcelona Supercomputing Center (BSC), lead by Víctor Guallar, in collaboration of Nostrum Biodiscovery ...

New chemical lego blocks for health solutions

by IBEC - Institut de Bioenginyeria de Catalunya

4 years ago
chemical lego, health, drugs

IBEC researchers develop new multi-responsive molecules able to self-assemble in water forming fiber-like structures. The so-called discotic molecules show responsiveness to temperature, light, pH, an...

Two anti-inflammatory drugs found that inhibit the replication of the COVID-19 virus

by Universitat Rovira i Virgili

4 years ago
drugs, inflammatory, covid-19

A study by the URV’s Cheminformatics and Nutrition research group has shown that an anti-inflammatory drug for humans and another for animals inhibit a key enzyme in the replication and transcriptio...